Press Releases

August 7, 2007
Milestone Study Reveals Mortality Prediction Power of ST2 in Dyspneic Patients

April 2, 2007
Stroke Drug Development Expert Joins Innovative CNS Therapeutics Company

March 27, 2007
Access Scientific Debuts 'The Wand,' Innovative Micro-Access Safety Introducer

March 19, 2007
OrthoDerm™ Enters Phase 2b Clinical Testing

June 14, 2006
Drug Prevents Brain Swelling After Stroke

March 16, 2006
Two Top Executives Named to Lead Innovative
Therapeutics Company

August 11, 2005
Critical Diagnostics Strengthens Leadership Team

August 7, 2005
Remedy Pharmaceuticals Secures Seed Financing

January 13, 2005
Company Develops Patch to Accelerate Healing of Injured Tendons

October 18, 2004
Critical Diagnostic Secures Seed Financing

June 8, 2004
Access Scientific Secures Seed Financing  

May 24, 2004
Bidshift Secures $3.5 Million in Funding

 

 

 


Access Scientific Debuts 'The Wand,' Innovative Micro-Access Safety Introducer

NEW YORK, NY — (BUSINESS WIRE) — Thursday March 29, 8:00 am ET — The Wand™ All-in-One Micro-Access Safety Introducer received a strongly positive reception from clinicians at the recent annual meeting of the Society for Interventional Radiology (SIR).
The Wand is a unique, proprietary introducer that may provide faster and easier micro-access for all types of vascular access.

Developed by Access Scientific, Inc., the device could replace the Seldinger technique. The older Seldinger approach requires up to 12 steps and involves the use of several loose parts, while The Wand offers a simpler four-step procedure involving a single component.

Dr. Constantin Cope, a noted pioneer in micro-access, has described The Wand as "a promising bloodless development of the micro-access technique."

The device has potential advantages for both patients and clinicians in several applications. These may include:

  • Replacement of an entire micro-access kit with one integrated device;
  • Rapid insertion of central venous catheters (CVCs) and peripherally inserted central catheters (PICCs);
  • Diagnostic and interventional cardiology procedures;
  • Dialysis procedures and access to problem fistulae and grafts.

The device was conceived by Michael Tal, M.D., Director of Research in Interventional Radiology at Yale University School of Medicine. Access Scientific is a medical device company funded by Carrot Capital Healthcare Ventures, a seed- and early-stage venture capital fund.

Access Scientific is preparing to seek FDA 510(k) market clearance for The Wand. The device is protected by patents and patents pending, domestic and international. The 32nd Annual Meeting of the Society for Interventional Radiology was held in Seattle, March 2-5.